Previous 10 | Next 10 |
home / stock / alpmf / alpmf news
2023-12-15 18:20:05 ET More on Merck, Pfizer, etc. Pfizer: Dividend Boost At The Right Time Pfizer 2024 Guidance - Relentless COVID Pain Isn't Over Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Merck gets FDA approval for kidney cancer drug Welireg ...
2023-12-14 07:47:47 ET More on Apellis Pharma Apellis Pharmaceuticals: Focus Shifts Toward Market Share After Apparent Safety Resolution Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript Apellis Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings C...
2023-12-08 04:54:49 ET More on Pfizer, Astellas Pharma Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Astella...
2023-12-06 11:19:36 ET Summary Apellis addressed Syfovre's safety issues, improving its situation; still, initial concerns about severe side effects remain relevant. Syfovre's market potential is significant as the first GA treatment, but rare vasculitis cases and competition pose...
2023-12-01 09:18:27 ET More on Apellis Pharmaceuticals Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript Apellis Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Apellis Pharmaceuticals: Looking For Entry Around Crucial Q3 Earn...
2023-11-19 21:37:59 ET Summary Soros Fund Management's 13F portfolio value increased by 10% to $7.05B, with 209 positions. Top three individual stocks held were Horizon Therapeutics, Activision Blizzard, and Alphabet. New stakes included Activision Blizzard, Abcam plc, Novo No...
2023-11-07 19:06:24 ET Summary A phase 2 study is being advanced using EPI-7386 in combination with enzalutamide to treat patients with metastatic castration-resistant prostate cancer; Positive updated PSA data presented at medical conference. EPI-7386 is being advanced as a monot...
2023-11-05 12:17:29 ET Summary The UST yield curve has steepened and this could provide an opportunity to buy US banking stocks on weakness in a no-recession scenario. Japan and Eurozone exporters can benefit from a global downturn due to easier central bank policies depreciating ...
2023-10-27 16:13:47 ET Summary Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gastrointestinal disorders. The company's revenue-generating product is Linzess, which is approved for multiple GI indications. Ironwood recently a...
2023-10-23 14:25:26 ET More on Seattle Genetics Seagen Acquisition By Pfizer: A Strategic Power Move With Potential Windfalls For Investors Seagen ticks higher as EU approves $43B sale to Pfizer Pfizer likely turned over all documents to FTC for Seagen acquistion - r...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG (OTC:BAYRY) (OTC:BAYZF) will present detailed results from the Phase 3 studies OASIS 1 and 2, showing that the investi...
Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual pri...
Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) released topline results from the KEYNOTE-A39 Phase...